FDA rejects UniQure's AMT-130 data, sending shares tumbling as the company scrambles to find a path to approval.
California Governor Newsom's pivotal Prop 50 victory boosts his national profile, but faces criticism over misleading claims and environmental concerns.
FDA rejects UniQure's AMT-130 data, sending shares tumbling as the company scrambles to find a path to approval.
California Governor Newsom's pivotal Prop 50 victory boosts his national profile, but faces criticism over misleading claims and environmental concerns.